ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,275.38
0.54%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,330.03
0.11%
Brent Oil
81.47
0.82%
Bitcoin
68,570.84
1.21%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Arcturus Therapeutics Holdings Inc (ARCT) Share Price

ARCT Arcturus Therapeutics Holdings Inc

38.81
0.33 (0.86%)
01 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Arcturus Therapeutics Holdings Inc NASDAQ:ARCT NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.33 0.86 38.81 36.38 39.61 39.82 38.05 38.52 480,632 00:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 166.8M -29.73M -1.1044 -35.14 1.04B
 Type  Size  Price  Time  Units 
 9 6 39.56 23:25:06 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore ARCT News
28/05/202411:30BWArcturus Therapeutics Announces Positive Development for Cystic Fibrosis Program
22/05/202412:00GLOBEAchilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer Vaccines
20/05/202413:30BWNature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and Arcturus Therapeutics’ COVID-19 Vaccine
20/05/202413:30PRNUSNature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and Arcturus Therapeutics' COVID-19 Vaccine
15/05/202421:01BWArcturus Therapeutics to Attend Upcoming Investor & Scientific Conferences
08/05/202421:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/05/202421:05EDGAR2Form 8-K - Current report
Period
Draw mode
Data Downloads for ARCT

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Arcturus Therapeutics Holdings Inc Articles